| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
We`re out to change the course of medical science. Are you ready to rise to the challenge? Premier Research is not about being everything to everyone. Instead, our deep, focused expertise targets the therapeutic areas and indications where today`s biotech and specialty pharma pioneers are doing the most amazing work. We`re 1,000 employees strong and operate in more than 20 countries, delivering unmatched expertise, operational skills, and dedication to meeting customers` most challenging needs. Join us and meet some of the brightest minds in clinical development today — people who apply their best thinking to every project, recognizing that what they do significantly affects the lives and well-being of customers, patients, physicians, and colleagues. You`ll enjoy great benefits and very flexible working conditions in a company that values your contributions, rewards your achievements, and is committed to helping you reach your full potential.
Cardium Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Cardium Therapeutics, Inc., please visit www.cardiumthx.com
Physicians Academy for Clinical and Management Excellence is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Emergency Care Programs is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.